| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
4 |
| issn |
1167-7422 |
| issueIdentifier |
95 |
| pageRange |
113-4 |
| publicationName |
Prescrire international |
| startingPage |
113 |
| bibliographicCitation |
Entacapone: hepatitis (continued). The risk of liver damage is being confirmed. It is better not to expose parkinsonian patients to this drug. Prescrire Int. 2008 Jun;17(95):113–4. PMID: 18630358. |
| date |
200806 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/18630358 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21259
https://portal.issn.org/resource/ISSN/1167-7422 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Entacapone: hepatitis (continued). The risk of liver damage is being confirmed. It is better not to expose parkinsonian patients to this drug |
| discusses |
http://id.nlm.nih.gov/mesh/M0003648
http://id.nlm.nih.gov/mesh/M0014878 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D002396Q000633
http://id.nlm.nih.gov/mesh/D056486
http://id.nlm.nih.gov/mesh/D009570Q000633 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005060
http://id.nlm.nih.gov/mesh/D002396Q000627
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D009570Q000627
http://id.nlm.nih.gov/mesh/D010300Q000188 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281081
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7987
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10611 |